Philips Respironics has issued another ventilator recall deemed the most serious type by the FDA as it may cause serious injury or death.

Philips Respironics has removed certain DreamStation devices due to programming errors that can result in failed therapy modes, according to the U.S. Food and Drug Administration.

Roy Jakobs, who joined Philips in 2010 and became CEO in 2022 amid a major crisis, has since played a key role in stabilizing ...

NOW has launched rtNOW Engage, a suite of turnkey service lines to support durable medical equipment (DME) companies, including follow-up checks for non-invasive ventilation (NIV) and BiPAP patients ...

Here are four of the latest recalls and corrections reported to the FDA.

Girija Surgicals, a leading healthcare and surgical equipment provider in the coastal Karnataka region, is set to inaugurate ...

Adults with type 2 diabetes and obstructive sleep apnea who use continuous positive airway pressure may reduce their risk for ...

CPAP therapy is linked to improved relationships and sexual satisfaction in patients with OSA and their partners.

Nyxoah announced that it continued the expansion of its neuromodulation for obstructive sleep apnea (OSA) to the Middle East.

In patients with both type 2 diabetes and obstructive sleep apnea, treatment with CPAP may reduce the risk for mortality.

Patients with OSA treated with CPAP have a lower incidence and recurrence of atrial fibrillation vs those not treated with CPAP.